EB World Congress is an independent, global congress on epidermolysis bullosa (EB) bringing together the world’s leading experts in EB research, clinical management, and the EB Community.
This pooling of state-of-the-art knowledge across the key stakeholders not only gives guidance to the professionals involved in EB, but also helps in the development of strategies for the research, regulatory, funding, and healthcare communities.
Fostering strategic and collaborative work with an emphasis on current scientific and clinical data, this meeting makes a difference in the world of EB and helps raise awareness of the condition.
This inaugural event (EB 2020) is being organised and funded by DEBRA UK in partnership with Cure EB with support from its Sponsors and as part of an alliance of more than 20 rare disease and dermatology organisations worldwide.